Status:
COMPLETED
Pre-Operative Effects of Mifepristone on Dilation and Evacuation Services
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Santa Clara Valley Medical Center
Conditions:
Legally Induced Abortion Without Mention of Complication
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This research study investigates the use of a drug, mifepristone, given before second trimester abortion. Mifepristone is a medication that is approved for medical abortion during the first trimester....
Eligibility Criteria
Inclusion
- \>18 years old
- Viable, Singleton pregnancy
- Voluntarily seeking abortion between 19 and 24 wks gestation
- Able to give informed consent and comply with study protocol
- Fluent in English or Spanish
Exclusion
- Allergy to misoprostol or mifepristone
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01862991
Start Date
July 1 2013
End Date
June 1 2016
Last Update
February 14 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Santa Clara Valley Medical Center
San Jose, California, United States, 95128
2
Stanford University Medical Center
Stanford, California, United States, 94305